Complementary Medicines
Our aim is to clarify the often confusing issues surrounding the complementary medicines industry. We assist our clients to comply with the current requirements for their individual needs. Our clients have come to rely on our expert advice and prompt service.
Complementary medicines are subdivided into the following classes:
- Anthroposophical medicines;
- Aromatherapeutic essential oils;
- Ayurvedic medicines;
- Biochemic tissue salts;
- Chinese medicines;
- Gemmotherapeutic substances;
- Flower and gem essences;
- Herbal medicines
- Homoeopathic medicines;
- Homotoxicological medicines;
- Mineraloid substances;
- Nutraceuticals;
- Nutritional food substances;
- Sowa Rigpa medicines; and
- Unani-Tibb medicines.
The Biodiversity Act (Act 10 of 2004)
In ensuring sustainable utilisation of indigenous and endemic biological resources, while promoting fair and equitable sharing of benefits, the National Department of Environmental Affairs through the National Environmental Management: Biodiversity Act (NEMBA), Act 10 of 2004 developed the Bioprospecting, Access and Benefit Sharing Regulations which came into force on 1 April 2008.
These regulations govern the utilisation of indigenous biological resources or associated traditional knowledge, targeted for research and development (bioprospecting), with an intention to commercialise the end product - through a permitting systems.
